Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 5, 2005-10 ,pp. : 355-375

Bentham Science Publishers

Access to resources Recommend Favorite

Endocrine Effects of Erythropoietin in Cancer Patients

By Lissoni Paolo   Perego Maristella   Veronese Elisabetta   Fumagalli Gabriele   Brivio Fernando   Colciago Massimo   Messina Giusy   Rovelli Franco   Brivio Rinaldo   Gardani Gianstefano  

Hematology, Vol. 9, Iss. 5-6, 2004-10 ,pp. : 363-367

Maney Publishing

Access to resources Recommend Favorite

Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice

By Sasaki Yusuke  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 692-700

Springer Publishing Company

Access to resources Recommend Favorite

Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation

By Baron F.   Sautois B.   Baudoux E.   Matus G.   Fillet G.   Beguin Y.  

Experimental Hematology, Vol. 30, Iss. 6, 2002-06 ,pp. : 546-554

Elsevier

Access to resources Recommend Favorite

Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34 + hematopoietic progenitor cells

By Myklebust J.H.   Blomhoff H.K.   Rusten L.S.   Stokke T.   Smeland E.B.  

Experimental Hematology, Vol. 30, Iss. 9, 2002-09 ,pp. : 990-1000

Elsevier

Access to resources Recommend Favorite